Company profile
Aquarius Surgical Technologies Inc.
OTC: AQQRF · Healthcare · Medical - Devices
Canadian filerHQ Toronto, ONReports USD
#1068 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 26
v0.1 · 5/100 weight · pillars only
↑ growth stability, disclosure history · ↓ workforce scale, balance-sheet leverage
Methodology →Revenue TTM
$66.2k
Rev growth YoY (TTM)
+0.3%
Net income (FY)
-$839.0k
Employees
3
as of 2026-08-28
Market cap
$115.9k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$65.6k91.2k CAD2025
Net income-$839.0k-1.2M CAD2025
Operating income-$392.1k-545.6k CAD2025
Total assets$1.4M1.9M CAD2025
Liabilities$5.4M7.7M CAD2025
Equity-$4.0M-5.8M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Aquarius Surgical Technologies Inc.’s revenue?
Aquarius Surgical Technologies Inc. booked $65.6k in FY2025 revenue, contracting 57% year over year — slower than 83% of Healthcare companies we track, at a -1279.8% net margin.
Peers · Healthcare
MYND Life Sciences Inc.——Vivos Inc.48DNeutra Corp.——Inovio Pharmaceuticals, Inc.37DKali, Inc.——Connect Biopharma Holdings Limited25DKey facts
CEOLorne Stewart MacFarlane
SectorHealthcare
IndustryMedical - Devices
HeadquartersToronto, ON
ExchangeOTC: AQQRF
Employees3
IPO date2017-09-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.